finally, this one is a long shot, david pyott of allergan. u can imagine feeling vindicated after they sold. i got off the phone with david and he is not interested in taking over the ceo role but is working on a book about his experiences with the valeant battle and said they keep adding chapters and chapters onto it. >> wow, he's working on a book. that tlb interesting. >> how about howard shuler, they asked him, the chief financial officer to step down from the board to resign. he refused to do that. he could be something of a disruptive force there, couldn't he? >> absolutely. already today the story seems to be howard shuller and this battle. he was the interim ceo and now they are saying there was improper conduct involved and through his lawyers he's saying there was no improper conduct, he's not stepping down from the board. this will be interesting to continue to watch. >> meg, thank you. so many elements follow here, meg tirrell and jim cramer floating an idea earlier. >> valeant is going up because they feel there's a grown-up in ch